2015
Release time：2015-03-15 10:42
The phase I/II clinical trials of GT0918 (Proxalutamide tablets) project for prostate cancer indications have been launched in the United States
The Group has obtained Series B investment of approximately USD10 million
The GT0918 (Proxalutamide tablets) project has obtained clinical trials permission for prostate cancer indications in China and the United States, and phase I clinical trials have been launched in China
recommend News
2025-06-25
Find Us
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Complaints and Suggestions Tel: +86 512 62639935 Email: pr@kintor.com.cn
Copyright: Kintor Pharmaceutical Limited retains all copyrights.
Powered by 300.cn